M Beltramo Selected Research

Ischemia

6/2000

Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Beltramo Research Topics

Disease

2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 07/2001 - 05/2000
1	Pain (Aches) 09/2009
1	Chronic Pain 03/2006
1	Hyperalgesia 03/2006
1	Brain Ischemia (Cerebral Ischemia) 06/2000
1	Infarction (Infarctions) 06/2000
1	Ischemia 06/2000
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2000
1	Catalepsy 05/2000
1	Hypokinesia (Bradykinesia) 05/2000
1	Astrocytoma (Pilocytic Astrocytoma) 04/2000

Drug/Important Bio-Agent (IBA)

2	AM 1241IBA 09/2009 - 03/2006
2	N-(4-hydroxyphenyl)arachidonylamide (AM404)IBA 07/2001 - 05/2000
2	Pharmaceutical PreparationsIBA 06/2000 - 05/2000
1	1- (2,3- dichlorobenzoyl)- 5- methoxy- 2- methyl- (2- (mopholin- 4- yl)ethyl)- 1H- indoleIBA 09/2009
1	Analgesics (Analgesic Drugs)IBA 03/2006
1	Dopamine Agonists (Dopamine Agonist)IBA 07/2001
1	alanylaspartic acidIBA 06/2000
1	N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketoneIBA 06/2000
1	KetonesIBA 06/2000
1	CytokinesIBA 06/2000
1	CaspasesIBA 06/2000
1	Caspase InhibitorsIBA 06/2000
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 05/2000
1	RimonabantIBA 05/2000
1	Cannabinoid Receptor AgonistsIBA 05/2000
1	anandamide (arachidonylethanolamide)IBA 04/2000

Therapy/Procedure

1	Ligation 03/2006
1	Analgesia 05/2000